Mapping of the epitope within region 80-109 of NY-ESO-1. ELISPOT assay with CD8+ T cells from patient UC-098 presensitized with NY-ESO-1 peptide 80-109 and tested against histocompatible B-EBV targets pulsed with peptides at 10 µM (A and B) or at various concentrations (C).